Join leading RNA scholars on Tuesday, Dec. 1, and Wednesday, Dec. 2, 2026, as they share new insights into diverse areas of RNA research, including computation, biophysics, biochemistry and disease pathology. The symposium takes place at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation &…
For "outstanding lifetime contributions to natural products chemistry," and "significantly improving medicine and human health," with RNA-targeting innovations, two prestigious awards go to Wertheim UF Scripps scientists.
Looking to the Genome to Address ‘Undruggable’ Diseases including Parkinson’s, ALS, Cancer and More Biochemist Matthew Disney, Ph.D., has found that many incurable diseases can potentially be cured via key RNA. He’s racing against time to create novel treatments and get them to patients. Original…
The Journey from Molecule to Medicine – A Photo Tour From molecules to medicines, every cure begins with understanding. At the Wertheim UF Scripps Institute, we unlock tomorrow’s therapies by understanding the complexity of life. “We can also apply this to areas of unmet need that maybe a pharmaceutical…
stopping DiSease by understanding its root cause…
Mapping vulnerabilities in the SARS-CoV-2 genome, made of RNA, reveals a path to fighting more than COVID-19.
A Parkinson's disease project from the lab of chemist Matthew D. Disney, Ph.D., has received a boost from a nonprofit focused on helping scientists translate their discoveries into treatments.
Molecular biologist Ezgi Hacisuleyman, Ph.D., investigates how neurons respond to signals, changing in milliseconds. She recently joined the institute from The Rockefeller University.
A new discovery from the lab of chemist Matthew Disney, Ph.D., takes its inspiration from Greek mythology. The compound is a chimera, and it battles a toxic cause of Parkinson's in two ways.
